You have 9 free searches left this month | for more free features.

Maximum Observed Plasma Concentration (Cmax)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Maximum Observed Plasma Glucose Concentration (Cmax) Trial in Boston (Orange flavored beverage)

Completed
  • Maximum Observed Plasma Glucose Concentration (Cmax)
  • Orange flavored beverage
  • Boston, Massachusetts
    Tufts University
Mar 8, 2021

Anesthesia Trial in Seoul (Remifentanil (Limited) - Target Controlled Infusion system, Remifentanil (Control) - Target

Not yet recruiting
  • Anesthesia
  • Remifentanil (Limited) - Target Controlled Infusion system
  • Remifentanil (Control) - Target Controlled Infusion system
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jun 20, 2022

Hypertension, Heart Failure Trial in San Antonio (Prazosin HCl 2mg, Prazosin HCl 1 mg, Prazosin HCl 5 mg)

Completed
  • Hypertension
  • Heart Failure
  • Prazosin HCl 2mg
  • +2 more
  • San Antonio, Texas
    Clinical Trials of Texas, LLC
Jul 6, 2022

Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)

Recruiting
  • Sickle Cell Disease
  • San Antonio, Texas
    ICON Early Phase Services, LLC
Jul 31, 2023

Healthy Volunteers Trial (ABP 501, Adalimumab)

Completed
  • Healthy Volunteers
  • (no location specified)
Aug 9, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Pharmacokinetics Trial in Burnaby (Quercetin LipoMicel (250 mg), Quercetin LipoMicel (500 mg), Quercetin LipoMicel (1000 mg))

Completed
  • Pharmacokinetics
  • Quercetin LipoMicel (250 mg)
  • +3 more
  • Burnaby, British Columbia, Canada
    ISURA
Nov 3, 2022

Severe Hepatic Impairment Trial in San Antonio (Rifaximin)

Recruiting
  • Severe Hepatic Impairment
  • San Antonio, Texas
    Valeant Site 01
Sep 7, 2022

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

COVID-19 Trial (Placebo for SLV213, SLV213)

Not yet recruiting
  • COVID-19
  • (no location specified)
Nov 22, 2023

Healthy Volunteers Trial (Atogepant, Ubrogepant)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 30, 2023

Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

Completed
  • Ulcerative Colitis (UC)
  • Crohn's Disease
  • Coronado, California
  • +5 more
Oct 20, 2022

T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 1, 2023

Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)

Completed
  • Healthy Volunteer
  • GFH312 100 mg
  • +3 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

Healthy Female Trial in Edegem (Milvexian, Midazolam, Ethinylestradiol)

Not yet recruiting
  • Healthy Female
  • Edegem, Belgium
    SGS Belgium NV
Jan 23, 2023

Healthy Trial in Madrid (Minoxidil Tablets, Minoxidil topical solution 20 mg/ml)

Not yet recruiting
  • Healthy
  • Minoxidil Tablets
  • Minoxidil topical solution 20 mg/ml
  • Madrid, Spain
    Hospital Universitario de la Princesa
Aug 25, 2023

Pain Trial in Harrow (VX-973, Placebo, Midazolam)

Recruiting
  • Pain
  • Harrow, United Kingdom
    PAREXEL International
May 17, 2023

Early-Onset Alzheimer Trial in Aurora, Amsterdam (ALN-APP, Placebo)

Recruiting
  • Early-Onset Alzheimer Disease
  • Indianapolis, Indiana
  • +5 more
Jan 19, 2023

Advanced Solid Tumor Trial in Australia, New Zealand, United States (BGB-A445, tislelizumab)

Recruiting
  • Phase 1a:Advanced Solid Tumors; Phase 1b: Non-small Cell Lung Cancer (NSCLC) and Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
  • +11 more
Aug 25, 2022

Healthy Volunteers Trial in Lenexa (BMS-986419, Caffeine, Bupropion)

Not yet recruiting
  • Healthy Volunteers
  • Lenexa, Kansas
    Local Institution - 0001
Jun 27, 2023

Healthy Trial in New Haven (Zavegepant 10 mg IN)

Not yet recruiting
  • Healthy
  • Zavegepant 10 mg IN
  • New Haven, Connecticut
    Pfizer Clinical Research Unit - New Haven
Jul 7, 2023

Healthy Trial in New Haven (PF-07295324, PF-07259955)

Active, not recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Aug 3, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Healthy Trial in Merksem (Ponesimod, Carbamazepine)

Recruiting
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jan 31, 2023